Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

Background and Aim The prevalence and clinical significance of extrahepatic autoimmune diseases (EHAIDs) have not been evaluated in a large cohort of primary biliary cholangitis (PBC). Methods The medical records of 1554 patients with PBC from 20 international centers were retrospectively reviewed....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastroenterology and hepatology 2021-04, Vol.36 (4), p.936-942
Hauptverfasser: Efe, Cumali, Torgutalp, Murat, Henriksson, Ida, Alalkim, Fatema, Lytvyak, Ellina, Trivedi, Hirsh, Eren, Fatih, Fischer, Janett, Chayanupatkul, Maneerat, Coppo, Claudia, Purnak, Tugrul, Muratori, Luigi, Werner, Mårten, Muratori, Paolo, Rorsman, Fredrik, Onnerhag, Kristina, Nilsson, Emma, Heurgué‐Berlot, Alexandra, Demir, Nurhan, Semela, David, Kıyıcı, Murat, Schiano, Thomas D, Montano‐Loza, Aldo J, Berg, Thomas, Ozaslan, Ersan, Yoshida, Eric M, Bonder, Alan, Marschall, Hanns‐Ulrich, Beretta‐Piccoli, Benedetta Terziroli, Wahlin, Staffan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background and Aim The prevalence and clinical significance of extrahepatic autoimmune diseases (EHAIDs) have not been evaluated in a large cohort of primary biliary cholangitis (PBC). Methods The medical records of 1554 patients with PBC from 20 international centers were retrospectively reviewed. Development of decompensated cirrhosis (ascites, variceal bleeding, and/or hepatic encephalopathy) and hepatocellular carcinoma were considered clinical endpoints. Results A total of 35 different EHAIDs were diagnosed in 440 (28.3%) patients with PBC. Patients with EHAIDs were more often female (92.5% vs 86.1%, P 
ISSN:0815-9319
1440-1746
1440-1746
DOI:10.1111/jgh.15214